Skip to main content

Year: 2021

Aurora Mobile to Report Third Quarter 2021 Financial Results on November 23, 2021

SHENZHEN, China, Nov. 11, 2021 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading mobile developer service provider in China, today announced that it will release its unaudited financial results for the third quarter ended September 30, 2021 before the open of U.S. markets on Tuesday, November 23, 2021. Aurora Mobile’s management will host an earnings conference call on Tuesday, November 23, 2021 at 7:30 a.m. U.S. Eastern Time (8:30 p.m. Beijing time on the same day). Due to the outbreak of COVID-19, operator assisted conference calls are not available at the moment. All participants must register in advance to join the conference using the link provided below. Please dial in 15 minutes before the call is scheduled to begin. Conference access information will be provided upon...

Continue reading

Motorized Quadricycle Market Size to Hit USD 1,869.6 Million in 2028 at a CAGR of 12.1% | Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Fortune Business Insights™

Key Prominent Players Covered in the Motorized Quadricycle Market are Renault, Ingersoll Rand, Yogomo, Textron, Italcar Industrial S.r.l., Polaris Inc., Yamaha Golf-Car Company, Bajaj Auto and Others Pune, India, Nov. 11, 2021 (GLOBE NEWSWIRE) — The global motorized quadricycle market is set to gain momentum from the increasing investment of OEMs in research and development activities. They are striving to enhance the passenger’s safety by launching environmentally friendly and fuel-efficient vehicles. Tesla, for instance, introduced a new feature named Navigate on Autopilot in 2018. It enables the car to navigate, accelerate, change lanes, or decelerate on its own. This information is given by Fortune Business Insights™, in its report, titled “Motorized Quadricycle Market, 2021-2028.” As per the report, the market size is projected...

Continue reading

Global Bone Growth Stimulator Market to Reach USD 2.55 Billion by 2028 | Market Projection By Technology, Major key players, Growth, Revenue, CAGR, Regional Analysis, Industry Forecast

Key Companies in Bone Growth Stimulator Market are Orthofix Holdings, Inc. (Texas, U.S.) , Zimmer Biomet (Warsaw, U.S.) , Depuy Synthes. (New Brunswick, U.S.) , Stryker (Kalamazoo, U.S.) , Bioventus LLC. (North Carolina, U.S.) , Medtronic Plc (Dublin, Ireland) , DJO, LLC. (California, U.S) , Arthrex, Inc. (Florida, U.S.) , Terumo Corporation (Tokyo, Japan) Pune, India, Nov. 11, 2021 (GLOBE NEWSWIRE) — The global bone growth stimulator market size is expected grow from USD 1.83 billion in 2021 to reach USD 2.55 billion by 2028, exhibiting a CAGR of 4.8% during the forecast period. The growing bone fractures and sports injuries around the world will promote the growth of the market in the forthcoming years, states Fortune Business Insights, in a report, titled “Bone Growth Stimulator Market, 2021-2028.” The market size stood at...

Continue reading

Kvika banki hf.: Presentation of the interim financial statement for Q3 2021

Attached is a presentation of the interim financial statement of the Kvika banki hf. group for the first nine months of 2021.  A meeting for shareholders and market participants will be held at 8:30 am today, Thursday 11 November, in the bank’s headquarters on the 9th floor at Katrínartún 2, 105 Reykjavík. The meeting will also be streamed on the website: https://www.kvika.is/fjarfestaupplysingar/fjarfestakynning-11-november-2021/Attachment2021-11-10 Kvika Q3 final

Continue reading

Mainz Biomed Appoints Former Roche Division President Heiner Dreismann to Strategic Advisory Board

Former President and CEO of Roche Molecular Systems and Member of Roche’s Global Diagnostic Executive CommitteeBERKELEY, Calif. and MAINZ, Germany, Nov. 11, 2021 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today the appointment of Dr. Heiner Dreismann to its Strategy Advisory Board. Dr. Dreismann had an illustrious career at Roche where he held multiple executive positions including, President and Chief Executive Officer of Roche Molecular Systems, serving as a Member of Roche’s Global Diagnostic and Executive Committee, and heading-up the Company’s global business development department. “To have such a notable leader in the diagnostics field join our team of advisors, is a testament...

Continue reading

SalMar – Invitation to presentation of the third quarter 2021 results

SalMar presents results for the third quarter 2021 on Wednesday 17 November 2021 at 08:00 CET from SalMars new harvesting- and processing facility on Senja in Northern Norway, InnovaNor. The presentation will held digitally on Norwegian webcast at 08:00 CET on www.salmar.no. There will be opportunity to send in questions during the Norwegian presentation. An English webcast (recording) will be available from 10:00 CET on www.salmar.no. CEO Gustav Witzøe, CFO & COO Trine Sæther Romuld and COO Industry and Sales Frode Arntsen will be representing the company. After the presentation two group conferences will be arranged, one in Norwegian at 12:00 am CET and one in English at 15:00 CET. For registration please send an email to Fearnley Securities, corp.access@fearnleys.com. The results will be available from 6:30 am CET at the company’s...

Continue reading

Sale of Brunton operations

Zug 2021-11-11Fenix ​​​Outdoor divests its Brunton operations Fenix ​​Outdoor has divested its Brunton operations to two private persons, today employees of the company, Brunton Outdoor Inc. Brunton is a leading manufacturer of equipment for navigation for various professional users and persons active in outdoor life, mainly in North America. As the customer base is significantly different from Fenix ​​Outdoors’ other brands, it is our belief that the brand can be developed better in a different ownership environment. The sale will not have a significant impact on Fenix ​​Outdoors’ financial key figures. Fenix ​​Outdoor wishes the new owners success in their management of the brand. For more information, please contact Thomas Lindberg, CFO, +46 703 33 17 63.AttachmentPress release Brunton

Continue reading

AB “Novaturas” strengthens its management team in Latvia

Leading tour operator in the Baltics AB “Novaturas” is strengthening its management team in Latvia. Sanda Roze with accumulated extensive experience in sales is joining the company as head of sales. Sanda will also be responsible for the organization of the Latvian office activities. “As tourism sector is recovering rapidly, we are amplifying our capacity and strengthening our sales team. I am happy to introduce and welcome Sanda joining our experienced management team. Sanda has many years of experience in sales in the hospitality industry. She will be responsible for strengthening and developing relations with our partners travel agencies in Latvia and the development of other distribution channels. Sanda will also be responsible for the organization of the Latvian office and strengthening the company’s positions in the Latvian...

Continue reading

Allarity Therapeutics’ Oral PARP Inhibitor, Stenoparib, Demonstrates Pre-clinical Antiviral Activity Against Delta Variant of Coronavirus

Current positive results with delta variant B.1.617.2 follows previous pre-clinical tests, including testing of alpha variant B.1.1.7 (“British” variant),beta variant B.1351 (“South African” variant), and gamma variant P.1 (“Brazilian” variant). Allarity Therapeutics is planning to submit findings to U.S. National Institutes of Health (NIH)for funding opportunities as part of the new Antiviral Program for Pandemics (APP) Press Release Hørsholm, Denmark (November 11, 2021) – Allarity Therapeutics A/S (“Allarity” or the “Company”) today announced positive results from the further pre-clinical testing of the antiviral activity of its oral PARP inhibitor, stenoparib, against Coronavirus variant B.1.617.2 (delta variant). The current in-vitro studies, focusing on SARS-CoV-2 lineage B.1.617.2, follow previous, positive pre-clinical test results...

Continue reading

GeoJunxion NV (ticker: GOJXN.AS) Formerly called AND International Publishers NV (AND.AS) Financial & Business update Q1 (July – September) 2021-22

Capelle aan den IJssel, The Netherlands, 11 November 2021, GeoJunxion reports 76% revenue growth, with strong reduction in Net Loss and Cash outflow for the period July – September 2021 versus the same period in 2020. Please note that the current financial year will cover a 12-month period from 1 July 2021 to 30 June 2022.  The previous financial year covered 18 months from 1 January 2020 to 30 June 2021 and was an eventful period, during which the Company went through a significant transformation, which, in part, is still in progress. Consequently, this is the first Financial and Business update of the new financial year 2021-22, covering the first 3 months from 1 July to 30 September 2021. Looking back at this first quarter, GeoJunxion’s business continued to show resilience and good performance, in spite of the fact that this quarter...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.